Institutional investors purchased a net $4.2 million shares of UNIS during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 43.04% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PORTFOLIO 21 INVESTMENTS, INC. Sold 305.00 shares of Unilife Corp